{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T22:14:15Z","timestamp":1795126455380,"version":"4.10.3"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the opening project of State Key Laboratory of Explosion Science and Technology","award":["KFJJ23-09M"],"award-info":[{"award-number":["KFJJ23-09M"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2019M653946"],"award-info":[{"award-number":["2019M653946"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"research project of 988th Hospital of Joint Logistic Support Force of PLA","award":["YNZX2024005"],"award-info":[{"award-number":["YNZX2024005"]}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["LHGJ20230703"],"award-info":[{"award-number":["LHGJ20230703"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06693-y","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T13:53:24Z","timestamp":1752155604000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Siramesine induced cell death of glioblastoma through inactivating the STAT3-MGMT signaling pathway"],"prefix":"10.1186","volume":"23","author":[{"given":"Xiaohang","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anhui","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinquan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingjie","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengzeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5675-0052","authenticated-orcid":false,"given":"Liyun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"6693_CR1","doi-asserted-by":"publisher","first-page":"100985","DOI":"10.1016\/j.neo.2024.100985","volume":"51","author":"J Zhao","year":"2024","unstructured":"Zhao J, Ma X, Gao P, Han X, Zhao P, Xie F, et al. Advancing glioblastoma treatment by targeting metabolism. Neoplasia (New York NY). 2024;51:100985. https:\/\/doi.org\/10.1016\/j.neo.2024.100985.","journal-title":"Neoplasia (New York NY)"},{"issue":"12 Suppl 2","key":"6693_CR2","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","volume":"22","author":"QT Ostrom","year":"2020","unstructured":"Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the united States in 2013\u20132017. Neurooncology. 2020;22(12 Suppl 2):iv1\u201396. https:\/\/doi.org\/10.1093\/neuonc\/noaa200.","journal-title":"Neurooncology"},{"issue":"12","key":"6693_CR3","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1093\/neuonc\/noy072","volume":"20","author":"A Karachi","year":"2018","unstructured":"Karachi A, Dastmalchi F, Mitchell DA, Rahman M. Temozolomide for Immunomodulation in the treatment of glioblastoma. Neurooncology. 2018;20(12):1566\u201372. https:\/\/doi.org\/10.1093\/neuonc\/noy072.","journal-title":"Neurooncology"},{"key":"6693_CR4","doi-asserted-by":"publisher","unstructured":"Yun D, Liang J, Wang X, Fan J, Wang X, Li J et al. TCAF2 drives glioma cellular migratory\/invasion properties through STAT3 signaling. Molecular and cellular biochemistry. 2023.https:\/\/doi.org\/10.1007\/s11010-023-04891-0","DOI":"10.1007\/s11010-023-04891-0"},{"key":"6693_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/tox.24178","author":"Y-C Chiang","year":"2024","unstructured":"Chiang Y-C, Selvam P, Liu Y-X, Shih P-C, Chen N-F, Kuo H-M, et al. STAT3 phosphorylation inhibitor Bt354 exhibits anti-neoplastic activity in glioblastoma multiforme cells. Environ Toxicol. 2024. https:\/\/doi.org\/10.1002\/tox.24178.","journal-title":"Environ Toxicol"},{"issue":"27","key":"6693_CR6","doi-asserted-by":"publisher","first-page":"5042","DOI":"10.1038\/s41388-020-1348-7","volume":"39","author":"S Yu","year":"2020","unstructured":"Yu S, Yu X, Sun L, Zheng Y, Chen L, Xu H, et al. GBP2 enhances glioblastoma invasion through Stat3\/fibronectin pathway. Oncogene. 2020;39(27):5042\u201355. https:\/\/doi.org\/10.1038\/s41388-020-1348-7.","journal-title":"Oncogene"},{"key":"6693_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mce.2017.01.004","volume":"451","author":"N Chang","year":"2017","unstructured":"Chang N, Ahn SH, Kong DS, Lee HW, Nam DH. The role of STAT3 in glioblastoma progression through dual influences on tumor cells and the immune microenvironment. Mol Cell Endocrinol. 2017;451:53\u201365. https:\/\/doi.org\/10.1016\/j.mce.2017.01.004.","journal-title":"Mol Cell Endocrinol"},{"key":"6693_CR8","doi-asserted-by":"publisher","unstructured":"Zhang G, Hou S, Li S, Wang Y, Cui W. Role of STAT3 in cancer cell epithelial\u2013mesenchymal transition (Review). Int J Oncol. 2024;64(5). https:\/\/doi.org\/10.3892\/ijo.2024.5636.","DOI":"10.3892\/ijo.2024.5636"},{"issue":"4","key":"6693_CR9","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson DE, O\u2019Keefe RA, Grandis JR. Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018;15(4):234\u201348. https:\/\/doi.org\/10.1038\/nrclinonc.2018.8.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"6693_CR10","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1038\/s41467-025-57476-4","volume":"16","author":"CD Rouault","year":"2025","unstructured":"Rouault CD, Bansard L, Mart\u00ednez-Balsalobre E, Bonnet C, Wicinski J, Lin S, et al. Inhibition of the STAT3\/Fanconi anemia axis is synthetic lethal with PARP Inhibition in breast cancer. Nat Commun. 2025;16(1):2159. https:\/\/doi.org\/10.1038\/s41467-025-57476-4.","journal-title":"Nat Commun"},{"issue":"11","key":"6693_CR11","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/s41419-021-04329-9","volume":"12","author":"LL Wang","year":"2021","unstructured":"Wang LL, Luo J, He ZH, Liu YQ, Li HG, Xie D, et al. STEAP3 promotes cancer cell proliferation by facilitating nuclear trafficking of EGFR to enhance RAC1-ERK-STAT3 signaling in hepatocellular carcinoma. Cell Death Dis. 2021;12(11):1052. https:\/\/doi.org\/10.1038\/s41419-021-04329-9.","journal-title":"Cell Death Dis"},{"issue":"1","key":"6693_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12935-025-03681-6","volume":"25","author":"Y Dai","year":"2025","unstructured":"Dai Y, Cui C, Jiao D, Zhu X. JAK\/STAT signaling as a key regulator of ferroptosis: mechanisms and therapeutic potentials in cancer and diseases. Cancer Cell Int. 2025;25(1):83. https:\/\/doi.org\/10.1186\/s12935-025-03681-6.","journal-title":"Cancer Cell Int"},{"key":"6693_CR13","doi-asserted-by":"publisher","first-page":"5065","DOI":"10.2147\/ijn.S321343","volume":"16","author":"KS Allemailem","year":"2021","unstructured":"Allemailem KS, Almatroudi A, Alrumaihi F, Almatroodi SA, Alkurbi MO, Basfar GT, et al. Novel approaches of dysregulating lysosome functions in Cancer cells by specific drugs and its nanoformulations: A smart approach of modern therapeutics. Int J Nanomed. 2021;16:5065\u201398. https:\/\/doi.org\/10.2147\/ijn.S321343.","journal-title":"Int J Nanomed"},{"issue":"4","key":"6693_CR14","doi-asserted-by":"publisher","first-page":"487","DOI":"10.4161\/auto.5774","volume":"4","author":"MS Ostenfeld","year":"2008","unstructured":"Ostenfeld MS, H\u00f8yer-Hansen M, Bastholm L, Fehrenbacher N, Olsen OD, Groth-Pedersen L, et al. Anti-cancer agent Siramesine is a lysosomotropic detergent that induces cytoprotective autophagosome accumulation. Autophagy. 2008;4(4):487\u201399. https:\/\/doi.org\/10.4161\/auto.5774.","journal-title":"Autophagy"},{"issue":"19","key":"6693_CR15","doi-asserted-by":"publisher","first-page":"8975","DOI":"10.1158\/0008-5472.Can-05-0269","volume":"65","author":"MS Ostenfeld","year":"2005","unstructured":"Ostenfeld MS, Fehrenbacher N, H\u00f8yer-Hansen M, Thomsen C, Farkas T, J\u00e4\u00e4ttel\u00e4 M. Effective tumor cell death by sigma-2 receptor ligand Siramesine involves lysosomal leakage and oxidative stress. Cancer Res. 2005;65(19):8975\u201383. https:\/\/doi.org\/10.1158\/0008-5472.Can-05-0269.","journal-title":"Cancer Res"},{"key":"6693_CR16","unstructured":"Heading C, Siramesine H, Lundbeck. Current opinion in investigational drugs (London, England: 2000). 2001;2(2):266\u201370."},{"issue":"5","key":"6693_CR17","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1158\/0008-5472.Can-06-3520","volume":"67","author":"L Groth-Pedersen","year":"2007","unstructured":"Groth-Pedersen L, Ostenfeld MS, H\u00f8yer-Hansen M, Nylandsted J, J\u00e4\u00e4ttel\u00e4 M. Vincristine induces dramatic lysosomal changes and sensitizes cancer cells to lysosome-destabilizing Siramesine. Cancer Res. 2007;67(5):2217\u201325. https:\/\/doi.org\/10.1158\/0008-5472.Can-06-3520.","journal-title":"Cancer Res"},{"issue":"8","key":"6693_CR18","doi-asserted-by":"publisher","first-page":"e0182921","DOI":"10.1371\/journal.pone.0182921","volume":"12","author":"S Ma","year":"2017","unstructured":"Ma S, Dielschneider RF, Henson ES, Xiao W, Choquette TR, Blankstein AR, et al. Ferroptosis and autophagy induced cell death occur independently after Siramesine and lapatinib treatment in breast cancer cells. PLoS ONE. 2017;12(8):e0182921. https:\/\/doi.org\/10.1371\/journal.pone.0182921.","journal-title":"PLoS ONE"},{"key":"6693_CR19","doi-asserted-by":"publisher","unstructured":"Garcia EA, Bhatti I, Henson ES, Gibson SB. Prostate Cancer cells are sensitive to lysosomotropic agent Siramesine through generation reactive oxygen species and in combination with tyrosine kinase inhibitors. Cancers. 2022;14(22). https:\/\/doi.org\/10.3390\/cancers14225478.","DOI":"10.3390\/cancers14225478"},{"issue":"1","key":"6693_CR20","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12885-017-3162-3","volume":"17","author":"SS Jensen","year":"2017","unstructured":"Jensen SS, Petterson SA, Halle B, Aaberg-Jessen C, Kristensen BW. Effects of the lysosomal destabilizing drug Siramesine on glioblastoma in vitro and in vivo. BMC Cancer. 2017;17(1):178. https:\/\/doi.org\/10.1186\/s12885-017-3162-3.","journal-title":"BMC Cancer"},{"key":"6693_CR21","doi-asserted-by":"publisher","unstructured":"Villalpando-Rodriguez GE, Blankstein AR, Konzelman C, Gibson SB. Lysosomal destabilizing drug Siramesine and the dual tyrosine kinase inhibitor lapatinib induce a synergistic ferroptosis through reduced Heme Oxygenase-1 (HO-1) levels. Oxidative medicine and cellular longevity. 2019;2019:9561281https:\/\/doi.org\/10.1155\/2019\/9561281","DOI":"10.1155\/2019\/9561281"},{"issue":"1","key":"6693_CR22","doi-asserted-by":"publisher","first-page":"21835","DOI":"10.1038\/s41598-023-48777-z","volume":"13","author":"S Zhu","year":"2023","unstructured":"Zhu S, Guo J, Yu L, Liu J, Chen J, Xin J, et al. Synergistic effect of Cryptotanshinone and Temozolomide treatment against human glioblastoma cells. Sci Rep. 2023;13(1):21835. https:\/\/doi.org\/10.1038\/s41598-023-48777-z.","journal-title":"Sci Rep"},{"issue":"16","key":"6693_CR23","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, et al. AutoDock4 and AutoDockTools4: automated Docking with selective receptor flexibility. J Comput Chem. 2009;30(16):2785\u201391. https:\/\/doi.org\/10.1002\/jcc.21256.","journal-title":"J Comput Chem"},{"issue":"10","key":"6693_CR24","doi-asserted-by":"publisher","first-page":"e818","DOI":"10.1038\/cddis.2013.361","volume":"4","author":"MH \u010cesen","year":"2013","unstructured":"\u010cesen MH, Repnik U, Turk V, Turk B. Siramesine triggers cell death through destabilisation of mitochondria, but not lysosomes. Cell Death Dis. 2013;4(10):e818. https:\/\/doi.org\/10.1038\/cddis.2013.361.","journal-title":"Cell Death Dis"},{"key":"6693_CR25","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.Crc-24-0215","author":"A Chelariu-Raicu","year":"2025","unstructured":"Chelariu-Raicu A, Vu TC, Umamaheswaran S, Stur E, Hanjra P, Han Y, et al. IMGN853 induces autophagic cell death in combination therapy for ovarian cancer. Cancer Res Commun. 2025. https:\/\/doi.org\/10.1158\/2767-9764.Crc-24-0215.","journal-title":"Cancer Res Commun"},{"key":"6693_CR26","doi-asserted-by":"publisher","unstructured":"Lu J, Li C, Zhao T, Li F, Yao Z, Dong Y, et al. Sodium butyrate alleviates heat stress-Induced oxidative stress and skeletal muscle homeostasis disruption by promoting autophagy in mice. Nutrients. 2025;17(4). https:\/\/doi.org\/10.3390\/nu17040696.","DOI":"10.3390\/nu17040696"},{"key":"6693_CR27","doi-asserted-by":"publisher","first-page":"217532","DOI":"10.1016\/j.canlet.2025.217532","volume":"616","author":"H Liu","year":"2025","unstructured":"Liu H, Wang X, Li B, Xiang Z, Zhao Y, Lu M, et al. LncRNA HITT inhibits autophagy by attenuating ATG12-ATG5-ATG16L1 complex formation. Cancer Lett. 2025;616:217532. https:\/\/doi.org\/10.1016\/j.canlet.2025.217532.","journal-title":"Cancer Lett"},{"issue":"6","key":"6693_CR28","doi-asserted-by":"publisher","first-page":"542","DOI":"10.4161\/auto.4600","volume":"3","author":"N Mizushima","year":"2007","unstructured":"Mizushima N, Yoshimori T. How to interpret LC3 Immunoblotting. Autophagy. 2007;3(6):542\u20135. https:\/\/doi.org\/10.4161\/auto.4600.","journal-title":"Autophagy"},{"issue":"4","key":"6693_CR29","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4161\/auto.19496","volume":"8","author":"DJ Klionsky","year":"2012","unstructured":"Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012;8(4):445\u2013544. https:\/\/doi.org\/10.4161\/auto.19496.","journal-title":"Autophagy"},{"key":"6693_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/s0076-6879(08)03612-4","volume":"452","author":"G Bj\u00f8rk\u00f8y","year":"2009","unstructured":"Bj\u00f8rk\u00f8y G, Lamark T, Pankiv S, \u00d8vervatn A, Brech A, Johansen T. Monitoring autophagic degradation of p62\/SQSTM1. Methods Enzymol. 2009;452:181\u201397. https:\/\/doi.org\/10.1016\/s0076-6879(08)03612-4.","journal-title":"Methods Enzymol"},{"issue":"11","key":"6693_CR31","doi-asserted-by":"publisher","first-page":"8687","DOI":"10.3390\/cimb45110546","volume":"45","author":"J Chen","year":"2023","unstructured":"Chen J, Rodriguez AS, Morales MA, Fang X. Autophagy modulation and its implications on glioblastoma treatment. Curr Issues Mol Biol. 2023;45(11):8687\u2013703. https:\/\/doi.org\/10.3390\/cimb45110546.","journal-title":"Curr Issues Mol Biol"},{"issue":"3","key":"6693_CR32","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.neo.2015.01.003","volume":"17","author":"M Sen","year":"2015","unstructured":"Sen M, Pollock NI, Black J, DeGrave KA, Wheeler S, Freilino ML, et al. JAK kinase Inhibition abrogates STAT3 activation and head and neck squamous cell carcinoma tumor growth. Neoplasia. 2015;17(3):256\u201364. https:\/\/doi.org\/10.1016\/j.neo.2015.01.003.","journal-title":"Neoplasia"},{"issue":"8","key":"6693_CR33","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.1007\/s10238-023-01198-8","volume":"23","author":"N Jill","year":"2023","unstructured":"Jill N, Bhootra S, Kannanthodi S, Shanmugam G, Rakshit S, Rajak R, et al. Interplay between signal transducers and activators of transcription (STAT) proteins and cancer: involvement, therapeutic and prognostic perspective. Clin Experimental Med. 2023;23(8):4323\u201339. https:\/\/doi.org\/10.1007\/s10238-023-01198-8.","journal-title":"Clin Experimental Med"},{"key":"6693_CR34","doi-asserted-by":"publisher","first-page":"1023177","DOI":"10.3389\/fonc.2022.1023177","volume":"12","author":"B Huang","year":"2022","unstructured":"Huang B, Lang X, Li X. The role of IL-6\/JAK2\/STAT3 signaling pathway in cancers. Front Oncol. 2022;12:1023177. https:\/\/doi.org\/10.3389\/fonc.2022.1023177.","journal-title":"Front Oncol"},{"key":"6693_CR35","doi-asserted-by":"publisher","unstructured":"Wu M, Song D, Li H, Ahmad N, Xu H, Yang X, et al. Resveratrol enhances Temozolomide efficacy in glioblastoma cells through downregulated MGMT and negative Regulators-Related STAT3 inactivation. Int J Mol Sci. 2023;24(11). https:\/\/doi.org\/10.3390\/ijms24119453.","DOI":"10.3390\/ijms24119453"},{"key":"6693_CR36","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.2147\/cmar.S206175","volume":"11","author":"M Wu","year":"2019","unstructured":"Wu M, Song D, Li H, Yang Y, Ma X, Deng S, et al. Negative regulators of STAT3 signaling pathway in cancers. Cancer Manag Res. 2019;11:4957\u201369. https:\/\/doi.org\/10.2147\/cmar.S206175.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"6693_CR37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13046-024-02949-5","volume":"43","author":"Y Hu","year":"2024","unstructured":"Hu Y, Dong Z, Liu K. Unraveling the complexity of STAT3 in cancer: molecular Understanding and drug discovery. J Experimental Clin cancer Research: CR. 2024;43(1):23. https:\/\/doi.org\/10.1186\/s13046-024-02949-5.","journal-title":"J Experimental Clin cancer Research: CR"},{"issue":"1","key":"6693_CR38","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13046-023-02843-6","volume":"42","author":"S Qu","year":"2023","unstructured":"Qu S, Qi S, Zhang H, Li Z, Wang K, Zhu T, et al. Albumin-bound Paclitaxel augment Temozolomide treatment sensitivity of glioblastoma cells by disrupting DNA damage repair and promoting ferroptosis. J Experimental Clin cancer Research: CR. 2023;42(1):285. https:\/\/doi.org\/10.1186\/s13046-023-02843-6.","journal-title":"J Experimental Clin cancer Research: CR"},{"issue":"3","key":"6693_CR39","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3171\/2019.12.Jns192682","volume":"134","author":"T Yamada","year":"2020","unstructured":"Yamada T, Tsuji S, Nakamura S, Egashira Y, Shimazawa M, Nakayama N, et al. Riluzole enhances the antitumor effects of Temozolomide via suppression of MGMT expression in glioblastoma. J Neurosurg. 2020;134(3):701\u201310. https:\/\/doi.org\/10.3171\/2019.12.Jns192682.","journal-title":"J Neurosurg"},{"issue":"1","key":"6693_CR40","doi-asserted-by":"publisher","first-page":"vdae001","DOI":"10.1093\/noajnl\/vdae001","volume":"6","author":"M van der Meulen","year":"2024","unstructured":"van der Meulen M, Ramos RC, Voisin MR, Patil V, Wei Q, Singh O, et al. Differences in methylation profiles between long-term survivors and short-term survivors of IDH-wild-type glioblastoma. Neuro-oncology Adv. 2024;6(1):vdae001. https:\/\/doi.org\/10.1093\/noajnl\/vdae001.","journal-title":"Neuro-oncology Adv"},{"issue":"5","key":"6693_CR41","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.trecan.2020.02.010","volume":"6","author":"M Butler","year":"2020","unstructured":"Butler M, Pongor L, Su Y-T, Xi L, Raffeld M, Quezado M, et al. MGMT status as a clinical biomarker in glioblastoma. Trends cancer. 2020;6(5):380\u201391. https:\/\/doi.org\/10.1016\/j.trecan.2020.02.010.","journal-title":"Trends cancer"},{"issue":"2","key":"6693_CR42","doi-asserted-by":"publisher","first-page":"188616","DOI":"10.1016\/j.bbcan.2021.188616","volume":"1876","author":"MS Tomar","year":"2021","unstructured":"Tomar MS, Kumar A, Srivastava C, Shrivastava A. Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance. Biochim Et Biophys Acta Reviews cancer. 2021;1876(2):188616. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188616.","journal-title":"Biochim Et Biophys Acta Reviews cancer"},{"issue":"6","key":"6693_CR43","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1158\/1535-7163.Mct-11-0801","volume":"11","author":"S Kohsaka","year":"2012","unstructured":"Kohsaka S, Wang L, Yachi K, Mahabir R, Narita T, Itoh T, et al. STAT3 Inhibition overcomes Temozolomide resistance in glioblastoma by downregulating MGMT expression. Mol Cancer Ther. 2012;11(6):1289\u201399. https:\/\/doi.org\/10.1158\/1535-7163.Mct-11-0801.","journal-title":"Mol Cancer Ther"},{"key":"6693_CR44","doi-asserted-by":"publisher","first-page":"100307","DOI":"10.1016\/j.clinsp.2023.100307","volume":"78","author":"Z Zhong","year":"2023","unstructured":"Zhong Z, Zhong H. KIF22 promotes the proliferation and Glycolysis of melanoma by activating EGFR\/STAT3 signaling. Clin (Sao Paulo). 2023;78:100307. https:\/\/doi.org\/10.1016\/j.clinsp.2023.100307.","journal-title":"Clin (Sao Paulo)"},{"key":"6693_CR45","doi-asserted-by":"publisher","first-page":"119336","DOI":"10.1016\/j.jep.2025.119336","volume":"341","author":"XR Ding","year":"2025","unstructured":"Ding XR, Zheng RF, Kaderyea K, Han YL, Wang SB, Xu L, et al. Chinese herbal formula Regan Saibisitan alleviates airway inflammation of chronic bronchitis via inhibiting the JAK2\/STAT3 pathway. J Ethnopharmacol. 2025;341:119336. https:\/\/doi.org\/10.1016\/j.jep.2025.119336.","journal-title":"J Ethnopharmacol"},{"key":"6693_CR46","doi-asserted-by":"publisher","unstructured":"Sukhatme VP, Introduction. Repurposed drugs: teaching an old dog new tricks. Cancer J. 2019;25(2):81. https:\/\/doi.org\/10.1097\/ppo.0000000000000367.","DOI":"10.1097\/ppo.0000000000000367"},{"issue":"1","key":"6693_CR47","doi-asserted-by":"publisher","first-page":"vdae014","DOI":"10.1093\/noajnl\/vdae014","volume":"6","author":"RK Driscoll","year":"2024","unstructured":"Driscoll RK, Lyne SB, Voce DJ, Maraka S, Gondi V, Chmura SJ, et al. A multi-institutional phase I study of Acetazolamide with Temozolomide in adults with newly diagnosed MGMT-methylated malignant glioma. Neurooncol Adv. 2024;6(1):vdae014. https:\/\/doi.org\/10.1093\/noajnl\/vdae014.","journal-title":"Neurooncol Adv"},{"issue":"Suppl 3","key":"6693_CR48","doi-asserted-by":"publisher","first-page":"S214","DOI":"10.1055\/s-2004-832680","volume":"37","author":"HP Volz","year":"2004","unstructured":"Volz HP, Stoll KD. Clinical trials with Sigma ligands. Pharmacopsychiatry. 2004;37(Suppl 3):S214. https:\/\/doi.org\/10.1055\/s-2004-832680.","journal-title":"Pharmacopsychiatry"},{"key":"6693_CR49","doi-asserted-by":"publisher","first-page":"714","DOI":"10.3389\/fphar.2017.00714","volume":"8","author":"AM Klawonn","year":"2017","unstructured":"Klawonn AM, Nilsson A, R\u00e5dberg CF, Lindstr\u00f6m SH, Ericson M, Granseth B, et al. The Sigma-2 receptor selective agonist Siramesine (Lu 28\u2013179) decreases Cocaine-Reinforced Pavlovian learning and alters glutamatergic and dopaminergic input to the striatum. Front Pharmacol. 2017;8:714. https:\/\/doi.org\/10.3389\/fphar.2017.00714.","journal-title":"Front Pharmacol"},{"issue":"12","key":"6693_CR50","doi-asserted-by":"publisher","first-page":"6919","DOI":"10.1039\/c9ra09923a","volume":"10","author":"J Liu","year":"2020","unstructured":"Liu J, Tang M, Zhou Y, Long Y, Cheng Y, Zheng H. A siramesine-loaded metal organic framework nanoplatform for overcoming multidrug resistance with efficient cancer cell targeting. RSC Adv. 2020;10(12):6919\u201326. https:\/\/doi.org\/10.1039\/c9ra09923a.","journal-title":"RSC Adv"},{"issue":"3","key":"6693_CR51","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/S0022-3565(24)37124-1","volume":"283","author":"C S\u00e1nchez","year":"1997","unstructured":"S\u00e1nchez C, Arnt J, Costall B, Kelly ME, Meier E, Naylor RJ, et al. The selective sigma2-ligand Lu 28\u2013179 has potent anxiolytic-like effects in rodents. J Pharmacol Exp Ther. 1997;283(3):1323\u201332.","journal-title":"J Pharmacol Exp Ther"},{"key":"6693_CR52","doi-asserted-by":"publisher","first-page":"1482050","DOI":"10.3389\/fonc.2025.1482050","volume":"15","author":"X Ma","year":"2025","unstructured":"Ma X, Sun C, Ding X, Zhang Y, Deng T, Wang Y, et al. Advances in the treatment of glioma-related signaling pathways and mechanisms by Metformin. Front Oncol. 2025;15:1482050. https:\/\/doi.org\/10.3389\/fonc.2025.1482050.","journal-title":"Front Oncol"},{"key":"6693_CR53","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8833885","author":"B Liang","year":"2020","unstructured":"Liang B, Li SY, Gong HZ, Wang LX, Lu J, Zhao YX, et al. Clinicopathological and prognostic roles of STAT3 and its phosphorylation in glioma. Dis Markers. 2020. https:\/\/doi.org\/10.1155\/2020\/8833885.","journal-title":"Dis Markers"},{"issue":"8","key":"6693_CR54","doi-asserted-by":"publisher","first-page":"e0182282","DOI":"10.1371\/journal.pone.0182282","volume":"12","author":"M Tong","year":"2017","unstructured":"Tong M, Wang J, Jiang N, Pan H, Li D. Correlation between p-STAT3 overexpression and prognosis in lung cancer: A systematic review and meta-analysis. PLoS ONE. 2017;12(8):e0182282. https:\/\/doi.org\/10.1371\/journal.pone.0182282.","journal-title":"PLoS ONE"},{"issue":"2","key":"6693_CR55","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s11418-023-01757-z","volume":"78","author":"Y Fei","year":"2024","unstructured":"Fei Y, Zhang X, Wang X, Sun Y, He J, Liu X, et al. Upregulation of tumor suppressor PIAS3 by Honokiol promotes tumor cell apoptosis via selective Inhibition of STAT3 tyrosine 705 phosphorylation. J Nat Med. 2024;78(2):285\u201395. https:\/\/doi.org\/10.1007\/s11418-023-01757-z.","journal-title":"J Nat Med"},{"key":"6693_CR56","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.freeradbiomed.2025.01.022","volume":"229","author":"S Wu","year":"2025","unstructured":"Wu S, He Y, Li J, Zhuang H, Wang P, He X, et al. TREM2 alleviates sepsis-induced acute lung injury by attenuating ferroptosis via the SHP1\/STAT3 pathway. Free Radic Biol Med. 2025;229:111\u201326. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.01.022.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"6693_CR57","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/15548627.2023.2252301","volume":"20","author":"LH Wang","year":"2024","unstructured":"Wang LH, Wei S, Yuan Y, Zhong MJ, Wang J, Yan ZX, et al. KPT330 promotes the sensitivity of glioblastoma to Olaparib by retaining SQSTM1 in the nucleus and disrupting lysosomal function. Autophagy. 2024;20(2):295\u2013310. https:\/\/doi.org\/10.1080\/15548627.2023.2252301.","journal-title":"Autophagy"},{"key":"6693_CR58","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.3389\/fonc.2019.01568","volume":"9","author":"H Abe","year":"2019","unstructured":"Abe H, Natsumeda M, Okada M, Watanabe J, Tsukamoto Y, Kanemaru Y, et al. MGMT expression contributes to Temozolomide resistance in H3K27M-Mutant diffuse midline gliomas. Front Oncol. 2019;9:1568. https:\/\/doi.org\/10.3389\/fonc.2019.01568.","journal-title":"Front Oncol"},{"issue":"2","key":"6693_CR59","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/neuonc\/noy132","volume":"21","author":"A Mansouri","year":"2019","unstructured":"Mansouri A, Hachem LD, Mansouri S, Nassiri F, Laperriere NJ, Xia D, et al. MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges. Neuro Oncol. 2019;21(2):167\u201378. https:\/\/doi.org\/10.1093\/neuonc\/noy132.","journal-title":"Neuro Oncol"},{"issue":"1","key":"6693_CR60","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12964-018-0268-4","volume":"16","author":"MM Zegeye","year":"2018","unstructured":"Zegeye MM, Lindkvist M, F\u00e4lker K, Kumawat AK, Paramel G, Greneg\u00e5rd M, et al. Activation of the JAK\/STAT3 and PI3K\/AKT pathways are crucial for IL-6 trans-signaling-mediated pro-inflammatory response in human vascular endothelial cells. Cell Commun Signal. 2018;16(1):55. https:\/\/doi.org\/10.1186\/s12964-018-0268-4.","journal-title":"Cell Commun Signal"},{"issue":"12","key":"6693_CR61","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1080\/15548627.2023.2242696","volume":"19","author":"M Ou","year":"2023","unstructured":"Ou M, Cho HY, Fu J, Thein TZ, Wang W, Swenson SD, et al. Inhibition of autophagy and induction of glioblastoma cell death by NEO214, a Perillyl alcohol-rolipram conjugate. Autophagy. 2023;19(12):3169\u201388. https:\/\/doi.org\/10.1080\/15548627.2023.2242696.","journal-title":"Autophagy"},{"issue":"1","key":"6693_CR62","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41401-023-01157-9","volume":"45","author":"YH Yang","year":"2024","unstructured":"Yang YH, Li W, Ren LW, Yang H, Zhang YZ, Zhang S, et al. S670, an amide derivative of 3-O-acetyl-11-keto-\u03b2-boswellic acid, induces ferroptosis in human glioblastoma cells by generating ROS and inhibiting STX17-mediated fusion of autophagosome and lysosome. Acta Pharmacol Sin. 2024;45(1):209\u201322. https:\/\/doi.org\/10.1038\/s41401-023-01157-9.","journal-title":"Acta Pharmacol Sin"},{"key":"6693_CR63","doi-asserted-by":"publisher","first-page":"101112","DOI":"10.1016\/j.drup.2024.101112","volume":"76","author":"X Zhang","year":"2024","unstructured":"Zhang X, Tan Y, Li T, Tan D, Fu B, Yang M, et al. Intercellular adhesion molecule-1 suppresses TMZ chemosensitivity in acquired TMZ-resistant gliomas by increasing assembly of ABCB1 on the membrane. Drug Resist Updat. 2024;76:101112. https:\/\/doi.org\/10.1016\/j.drup.2024.101112.","journal-title":"Drug Resist Updat"},{"key":"6693_CR64","doi-asserted-by":"publisher","unstructured":"Cash TP, Alcal\u00e1 S, Rico-Ferreira MDR, Hern\u00e1ndez-Encinas E, Garc\u00eda J, Albarr\u00e1n MI, et al. Induction of lysosome membrane permeabilization as a therapeutic strategy to target pancreatic Cancer stem cells. Cancers (Basel). 2020;12(7). https:\/\/doi.org\/10.3390\/cancers12071790.","DOI":"10.3390\/cancers12071790"},{"key":"6693_CR65","doi-asserted-by":"publisher","unstructured":"Jin W. Role of JAK\/STAT3 signaling in the regulation of metastasis, the transition of Cancer stem cells, and chemoresistance of Cancer by Epithelial-Mesenchymal transition. Cells. 2020;9(1). https:\/\/doi.org\/10.3390\/cells9010217.","DOI":"10.3390\/cells9010217"},{"issue":"7","key":"6693_CR66","doi-asserted-by":"publisher","first-page":"e2307","DOI":"10.1038\/cddis.2016.208","volume":"7","author":"S Ma","year":"2016","unstructured":"Ma S, Henson ES, Chen Y, Gibson SB. Ferroptosis is induced following Siramesine and lapatinib treatment of breast cancer cells. Cell Death Dis. 2016;7(7):e2307. https:\/\/doi.org\/10.1038\/cddis.2016.208.","journal-title":"Cell Death Dis"},{"key":"6693_CR67","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8810785","author":"J Zhu","year":"2020","unstructured":"Zhu J, Xiong Y, Zhang Y, Wen J, Cai N, Cheng K, et al. The molecular mechanisms of regulating oxidative Stress-Induced ferroptosis and therapeutic strategy in tumors. Oxid Med Cell Longev. 2020. https:\/\/doi.org\/10.1155\/2020\/8810785.","journal-title":"Oxid Med Cell Longev"},{"issue":"8","key":"6693_CR68","doi-asserted-by":"publisher","first-page":"e18246","DOI":"10.1111\/jcmm.18246","volume":"28","author":"U Yilmaz","year":"2024","unstructured":"Yilmaz U, Tanbek K, Gul S, Koc A, Gul M, Sandal S. Intracerebroventricular BDNF infusion May reduce cerebral ischemia\/reperfusion injury by promoting autophagy and suppressing apoptosis. J Cell Mol Med. 2024;28(8):e18246. https:\/\/doi.org\/10.1111\/jcmm.18246.","journal-title":"J Cell Mol Med"},{"key":"6693_CR69","doi-asserted-by":"publisher","first-page":"e13019","DOI":"10.1590\/1414-431X2024e13019","volume":"57","author":"J Qu","year":"2024","unstructured":"Qu J, Wu L, Zhang M, Kan M, Chen H, Shi Y, et al. Serum autophagy-related gene 5 level in stroke patients: correlation with CD4\u2009+\u2009T cells and cognition impairment during a 3-year follow-up. Braz J Med Biol Res. 2024;57:e13019. https:\/\/doi.org\/10.1590\/1414-431X2024e13019.","journal-title":"Braz J Med Biol Res"},{"key":"6693_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2021.147747","author":"RJ Craven","year":"2022","unstructured":"Craven RJ, Frazier HN, Thibault O. Dependence of glucose transport on autophagy and GAPDH activity. Brain Res. 2022. https:\/\/doi.org\/10.1016\/j.brainres.2021.147747.","journal-title":"Brain Res"},{"key":"6693_CR71","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ejca.2020.10.036","volume":"144","author":"F Tabb\u00f2","year":"2021","unstructured":"Tabb\u00f2 F, Guerrera F, van den Berg A, Gaudiano M, Maletta F, Bessone L, et al. Kinomic profiling of tumour xenografts derived from patients with non-small cell lung cancer confirms their fidelity and reveals potentially actionable pathways. Eur J Cancer. 2021;144:17\u201330. https:\/\/doi.org\/10.1016\/j.ejca.2020.10.036.","journal-title":"Eur J Cancer"},{"issue":"1","key":"6693_CR72","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12987-023-00489-2","volume":"20","author":"MEM Stamp","year":"2023","unstructured":"Stamp MEM, Halwes M, Nisbet D, Collins DJ. Breaking barriers: exploring mechanisms behind opening the blood-brain barrier. Fluids Barriers CNS. 2023;20(1):87. https:\/\/doi.org\/10.1186\/s12987-023-00489-2.","journal-title":"Fluids Barriers CNS"},{"issue":"13","key":"6693_CR73","doi-asserted-by":"publisher","first-page":"e7385","DOI":"10.1002\/cam4.7385","volume":"13","author":"A Stradella","year":"2024","unstructured":"Stradella A, Johnson M, Goel S, Park H, Lakhani N, Arkenau HT, et al. Phase 1b study to assess the safety, tolerability, and clinical activity of Pamiparib in combination with Temozolomide in patients with locally advanced or metastatic solid tumors. Cancer Med. 2024;13(13):e7385. https:\/\/doi.org\/10.1002\/cam4.7385.","journal-title":"Cancer Med"},{"issue":"3","key":"6693_CR74","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/pcmr.13156","volume":"37","author":"V Ryd\u00e9n","year":"2024","unstructured":"Ryd\u00e9n V, El-Naggar AI, Koliadi A, Ladjevardi CO, Digkas E, Valachis A, et al. The role of Dacarbazine and Temozolomide therapy after treatment with immune checkpoint inhibitors in malignant melanoma patients: A case series and meta-analysis. Pigment Cell Melanoma Res. 2024;37(3):352\u201362. https:\/\/doi.org\/10.1111\/pcmr.13156.","journal-title":"Pigment Cell Melanoma Res"},{"key":"6693_CR75","doi-asserted-by":"publisher","first-page":"115187","DOI":"10.1016\/j.biopha.2023.115187","volume":"165","author":"A Rezaee","year":"2023","unstructured":"Rezaee A, Tehrany PM, Tirabadi FJ, Sanadgol N, Karimi AS, Ajdari A, et al. Epigenetic regulation of Temozolomide resistance in human cancers with an emphasis on brain tumors: function of non-coding RNAs. Biomed Pharmacother. 2023;165:115187. https:\/\/doi.org\/10.1016\/j.biopha.2023.115187.","journal-title":"Biomed Pharmacother"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06693-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06693-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06693-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T04:36:51Z","timestamp":1757219811000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06693-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6693"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06693-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"28 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"780"}}